• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

勘误：《SABRTooth可行性试验方案：一项关于比较立体定向消融放疗（SABR）与手术治疗外周I期非小细胞肺癌（NSCLC）且被认为手术切除并发症风险较高患者的III期随机对照试验的可行性和可接受性的研究》

Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.

作者信息

Snee M P, McParland L, Collinson F, Lowe C M, Striha A, Baldwin D R, Naidu B, Sebag-Montefiore D, Gregory W M, Bestall J, Hewison J, Hinsley S, Franks K N

机构信息

Department of Clinical Oncology, Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust, Beckett Street, Leeds, LS9 7TF UK.

Clinical Trials Research Unit (CTRU), Leeds Institute of Clinical Trials Research, University of Leeds, 71-75 Clarendon Road, Leeds, LS2 9PH UK.

出版信息

Pilot Feasibility Stud. 2016 Sep 12;2:55. doi: 10.1186/s40814-016-0095-6. eCollection 2016.

DOI:10.1186/s40814-016-0095-6
PMID:27976752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5154043/
Abstract

[This corrects the article DOI: 10.1186/s40814-016-0046-2.].

摘要

[本文更正了文章的数字对象标识符：10.1186/s40814-016-0046-2。]

相似文献

1
Erratum to: The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.勘误：《SABRTooth可行性试验方案：一项关于比较立体定向消融放疗（SABR）与手术治疗外周I期非小细胞肺癌（NSCLC）且被认为手术切除并发症风险较高患者的III期随机对照试验的可行性和可接受性的研究》
Pilot Feasibility Stud. 2016 Sep 12;2:55. doi: 10.1186/s40814-016-0095-6. eCollection 2016.
2
The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.“剑齿虎”可行性试验方案：一项旨在确定开展一项III期随机对照试验的可行性和可接受性的研究，该试验将立体定向消融放疗（SABR）与手术用于被认为手术切除并发症风险较高的外周I期非小细胞肺癌（NSCLC）患者进行比较。
Pilot Feasibility Stud. 2016 Feb 1;2:5. doi: 10.1186/s40814-016-0046-2. eCollection 2016.
3
SABRTooth: a randomised controlled feasibility study of stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I nonsmall cell lung cancer considered to be at higher risk of complications from surgical resection.SABRTooth：一项针对被认为手术切除并发症风险较高的外周I期非小细胞肺癌患者，对比立体定向消融放疗（SABR）联合手术与单纯手术的随机对照可行性研究。
Eur Respir J. 2020 Nov 12;56(5). doi: 10.1183/13993003.00118-2020. Print 2020 Nov.
4
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial.立体定向消融放疗联合或不联合免疫治疗早期或孤立性肺实质复发性淋巴结阴性非小细胞肺癌：一项开放标签、随机、2 期临床试验。
Lancet. 2023 Sep 9;402(10405):871-881. doi: 10.1016/S0140-6736(23)01384-3. Epub 2023 Jul 18.
5
Study protocol for the SARON trial: a multicentre, randomised controlled phase III trial comparing the addition of stereotactic ablative radiotherapy and radical radiotherapy with standard chemotherapy alone for oligometastatic non-small cell lung cancer.SARON试验的研究方案：一项多中心、随机对照III期试验，比较立体定向消融放疗联合根治性放疗与单纯标准化疗用于寡转移性非小细胞肺癌的疗效。
BMJ Open. 2018 Apr 17;8(4):e020690. doi: 10.1136/bmjopen-2017-020690.
6
Patient reported outcomes following video assisted thoracoscopic (VATS) resection or stereotactic ablative body radiotherapy (SABR) for treatment of non-small cell lung cancer: protocol for an observational pilot study (LiLAC).非小细胞肺癌患者接受电视辅助胸腔镜（VATS）切除术或立体定向消融体部放疗（SABR）后的患者报告结局：一项观察性预试验研究（LiLAC）方案
J Thorac Dis. 2017 Aug;9(8):2703-2713. doi: 10.21037/jtd.2017.07.35.
7
Short report: interim safety results for a phase II trial measuring the integration of stereotactic ablative radiotherapy (SABR) plus surgery for early stage non-small cell lung cancer (MISSILE-NSCLC).简短报告：一项测量立体定向消融放疗（SABR）联合手术治疗早期非小细胞肺癌（MISSILE-NSCLC）的II期试验的中期安全性结果。
Radiat Oncol. 2017 Jan 27;12(1):30. doi: 10.1186/s13014-017-0770-7.
8
Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?立体定向消融放疗与亚肺叶切除术对Ⅰ期非小细胞肺癌高危手术患者的疗效是否相当？
Interact Cardiovasc Thorac Surg. 2013 Nov;17(5):845-53. doi: 10.1093/icvts/ivt262. Epub 2013 Jul 30.
9
Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.立体定向消融放疗与标准放疗治疗Ⅰ期非小细胞肺癌（TROG 09.02 CHISEL）：一项 III 期、开放性标签、随机对照临床试验。
Lancet Oncol. 2019 Apr;20(4):494-503. doi: 10.1016/S1470-2045(18)30896-9. Epub 2019 Feb 12.
10
Systematic Review of Stereotactic Ablative Radiotherapy (SABR)/Stereotactic Body Radiation Therapy (SBRT) for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer.立体定向消融放疗（SABR）/立体定向体部放疗（SBRT）治疗Ⅰ期高危非小细胞肺癌患者的系统评价
Semin Thorac Cardiovasc Surg. 2025 Spring;37(1):89-98. doi: 10.1053/j.semtcvs.2024.10.005. Epub 2024 Dec 12.

引用本文的文献

1
Stereotactic body radiation therapy for early-stage non-small-cell lung cancer in octogenarians and older: an alternative treatment.立体定向体部放射治疗 80 岁及以上老年人早期非小细胞肺癌：一种替代治疗方法。
J Radiat Res. 2020 Jul 6;61(4):586-593. doi: 10.1093/jrr/rraa027.

本文引用的文献

1
The SABRTooth feasibility trial protocol: a study to determine the feasibility and acceptability of conducting a phase III randomised controlled trial comparing stereotactic ablative radiotherapy (SABR) with surgery in patients with peripheral stage I non-small cell lung cancer (NSCLC) considered to be at higher risk of complications from surgical resection.“剑齿虎”可行性试验方案：一项旨在确定开展一项III期随机对照试验的可行性和可接受性的研究，该试验将立体定向消融放疗（SABR）与手术用于被认为手术切除并发症风险较高的外周I期非小细胞肺癌（NSCLC）患者进行比较。
Pilot Feasibility Stud. 2016 Feb 1;2:5. doi: 10.1186/s40814-016-0046-2. eCollection 2016.